Co-Expression and Prognostic Significance of Putative CSC Markers CD44, CD133, Wild-Type EGFR and EGFRvIII in Metastatic Colorectal Cancer

Oncotarget - United States
doi 10.18632/oncotarget.26722
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Prognostic Significance of CD133 and Ezrin Expression in Colorectal Carcinoma

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2017English

Evaluation of CD44 and CD133 as Cancer Stem Cell Markers for Colorectal Cancer

Oncology Reports
MedicineCancer ResearchOncology
2012English

Co-Expression of CD133+/CD44+in Human Colon Cancer and Liver Metastasis

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2012English

EGFR Protein Expression in KRAS Wild-Type Metastatic Colorectal Cancer Is Another Negative Predictive Factor of the Cetuximab Therapy

Cancers
Cancer ResearchOncology
2020English

Prognostic Significance of TRAIL-R1 and TRAIL-R3 Expression in Metastatic Colorectal Carcinomas

European Journal of Cancer
Cancer ResearchOncology
2008English

FOLFIRI Plus Panitumumab in the Treatment of Wild-Type KRAS and Wild-Type NRAS Metastatic Colorectal Cancer

World Journal of Surgical Oncology
SurgeryOncology
2018English

Prognostic Significance of CD44 Expression in Adenocarcinoma of the Lung

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
1996English

Clinical Significance of HER2 and EGFR Expression in Colorectal Cancer Patients With Ovarian Metastasis

BMC Clinical Pathology
Forensic MedicinePathologyHistology
2019English

P009 to Investigate the Prognostic Factors and the Significance of TKI in Advanced NSCLC With Wild-Type EGFR

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy